In the News

August 1, 2022 :
Life Science Leader: Venture Philanthropy Launches Biotech from Within
An interview with Opus CEO Dr. Ben Yerxa on founding the company and the Opus mission. » Full Story
June 6, 2022 :
Eye on the Cure Podcast: Ash Jayagopal, PhD Interview
Foundation Fighting Blindness Host Ben Shaberman talks with Ash Jayagopal, chief scientific officer at Opus Genetics. » Full Story
December 2, 2021 :
WRAL TechWire: StartUP Spotlight An interview with Opus CEO Dr. Ben Yerxa on Opus’ mission.
Opus Genetics recently announced it would open its third preclinical trial, just a few months after the company formed with a $19 million seed financing round led by the venture capital arm of the Foundation Fighting Blindness, the RD Fund. » Full Story